comprehensive -WSS

comprehensive

author：entertainment 2025-08-12 08:28:30 - browse：3

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

hotspot

WSS

How to increase colonoscopy rates? Looks like an AI can help

Who gets to use the title 'doctor'?

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Celiac disease study examines precisely how gluten triggers injury

BMI, flaws aside, is found to be useful estimate of body fat in youth

ASCO: Palliative care found as helpful given virtually as in person

hotspot

comprehensive

leisure time

Bright Health sells Medicare Advantage business to Molina

Innovation in antibiotics is ailing. 'Brain drain' may kill it

In Memoriam: Notable people who died in 2023

Woman returns to dialysis after doctors remove transplanted pig kidney

Affirmative action in medical school literally saved lives

Georgia court denies Trump's request to quash DA's 2020 election probe

After affirmative action ruling, medical educators look to 'holistic review'

ASCO: Palliative care found as helpful given virtually as in person

What does generative AI mean for health care? We asked experts

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

focus

ASCO: Palliative care found as helpful given virtually as in person

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

With trial win, GSK could get blood cancer drug back on market

Argenx drug significantly slows progression of nerve disorder

Everything to know for the next Powerball drawing as jackpot hits $1 billion

HIV drugs protect against transmission, even in unprotected sex

hotspot

hotspot

Wikipedia

explore